InvestorsHub Logo
Followers 30
Posts 2825
Boards Moderated 0
Alias Born 03/15/2005

Re: None

Wednesday, 07/06/2005 10:40:55 AM

Wednesday, July 06, 2005 10:40:55 AM

Post# of 618741
NAWL.OB HUGE!!!!
SAN DIEGO - PRNewswire-FirstCall - Jul. 6
SAN DIEGO, Jul. 6 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (the "Company") -- (BULLETIN BOARD: NAWL) announced today that it has reached an arrangement with an international financier whereby the financier provided a guaranty for the repayment of up to $1.25 million of convertible notes that the Company sells to investors. Details of the transaction can be found in the Company's Form 10-QSB under Item 5. "Other Information".

James R. Arabia, Chairman and CEO of the Company, commented; "This deal has three important aspects to it. First, with the guaranty we believe that the Company's ability to raise needed working capital is significantly enhanced. Second, the structure of the deal is intended to give the Company an opportunity to preserve its $16.6 million net operating loss, which can be used to shelter future income. And third, it is a tremendous vote of confidence for NatureWell that a substantial international financier has agreed to provide this support. I am very pleased for NatureWell that we have reached this arrangement."

The Company currently markets its migraine relief product under the name MigraSpray, http://www.migraspray.com/, which is a patented spray formulation, delivered sublingually, containing the herb feverfew, intended to provide fast relief and prevention from pain and other symptoms associated with migraine headaches. NatureWell is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products.

Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the "safe harbor" provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.

NatureWell, Incorporated


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.